MorphoSys AG operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares MorphoSys AG with three other
miscellaneous service companies in Europe:
of UNITED KINGDOM
sales of £68.26 million [US$84.47 million]
(69.78 million Euros [US$76.52 million]
Innate Pharma S.A.
based in FRANCE
(68.97 million Euros [US$75.63 million]
During the year ended December of 2019, sales at
MorphoSys AG were 71.76 million Euro (US$78.68 million).
decrease of 6.1%
versus 2018, when the company's sales were 76.44 million Euro.
Contributing to the drop in overall sales was the 36.0% decline
in Proprietary Development, from 53.61 million Euro to 34.29 million Euro.
However, these declines were partially offset by the increase in sales of
Partnered Discovery (up 64.1% to 37.47 million Euro)